Global AI in Healthcare Investment Report (2011–H1 2016): $1.4B Raised Across 66 Deals

From 2011 to June 30, 2016, there were a total of 66 investment and financing transactions in the AI + healthcare sector, with the total funding amount reaching $1.4 billion. The data source for this report is the VCBeat database.

According to the VCBeat database, the number of startups in the “AI + Healthcare” sector increased year by year from 2011 to June 30, 2016, with a substantial rise in annual investment amounts each year after 2013. Notably, following Google’s acquisition of DeepMind in 2014, valuations for AI projects surged; that same year, Butterfly Network, a company dedicated to “AI + Medical Imaging,” secured $100 million in financing.

Represented by Butterfly Network, AI-powered medical imaging projects are among the most prominent segments within their respective niches.

From 2011 to June 30, 2016, among the sub-sectors of global AI + healthcare, medical imaging projects were the most numerous, totaling 16, with financing reaching $149 million. The main reasons for this trend are threefold: the maturity of image recognition technology, the widespread adoption of digital films, and the shortage of radiologists.

Data shows that the B2B model is one of the more favored approaches in the field of AI + healthcare.

Target users are predominantly involved in B2B projects with hospitals, which account for an average of 50% annually across all B2B initiatives. U.S. hospitals, incentivized by value-based care policies, are proactively adopting new technologies to enhance the quality of care and control healthcare costs.

Meanwhile, given that a large number of B2B projects in the “AI + Healthcare” sector are distributed across North America, where the insurance payment ecosystem is relatively mature, insurance companies have emerged as the second-largest target user group for B2B projects in this field.

The integration of artificial intelligence with healthcare aims to leverage new technologies to advance the medical field and improve patient health outcomes. Amid a wide range of diseases, chronic disease management projects—exemplified by diabetes treatment—are garnering the most attention within the AI-plus-healthcare sector.

In addition to the field of chronic disease management, some companies are also targeting niche scenarios such as genetic testing, intraoperative blood loss, breast cancer, and mental health.

The application of artificial intelligence in the healthcare sector is gradually expanding, with new business models and technologies emerging. Investors are also turning their attention to this field. Currently, there remains significant room for growth in this market.

The full version of this report provides an in-depth exposition on the overall landscape of AI+ healthcare investment, analysis of specific sectors, a chronological review, and business model analysis. To obtain the complete “Global AI Healthcare Venture Capital Data Analysis Report (2011–First Half of 2016),” please scan the QR code below or clickLink to Enter Recipient Email Address for the "AI Healthcare Venture Capital Data Analysis Report"Please provide your personal email address and information, and we will send you the full report via email.

(Scan the QR code above to access the full report)